{
  "id": 16119295,
  "title": "Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%",
  "url": "https://urgent.news/2026/10/22/moderna-and-merck-say-their-mrna-cancer-vaccine-cut-death-recurrence",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-22T22:12:19.000Z",
  "source": {
    "name": "Ars Technica Health",
    "slug": "ars-technica-health",
    "url": "https://arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Markers released top-line results today after previously reporting the trial succeeded.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "MarketWatch",
        "title": "Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.",
        "url": "https://urgent.news/2026/10/21/moderna-is-about-to-release-the-trial-results-for-its-cancer-vaccine",
        "published": "2026-10-21T15:00:00.000Z"
      },
      {
        "outlet": "BioPharma Dive",
        "title": "Moderna, Merck shares fall on eagerly anticipated cancer vaccine results",
        "url": "https://urgent.news/2026/10/22/moderna-merck-shares-fall-on-eagerly-anticipated-cancer-vaccine",
        "published": "2026-10-22T19:27:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}